Earnings Feed
Start Free
Home/Filings/4/0001055726-17-000010
4//SEC Filing

INOVIO PHARMACEUTICALS, INC. 4

Accession 0001055726-17-000010

$INOCIK 0001055726operating
View on SEC.govCompany Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 5:43 PM ET

Size

16.1 KB

Accession

0001055726-17-000010

Insider Transaction Report

Form 4
Period: 2017-03-09
INOVIO PHARMACEUTICALS, INC.INO
Sardesai Niranjan
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2017-03-09$6.61/sh−7,648$50,553→ 80,865 total
  • Exercise/Conversion

    Common Stock

    2017-03-10+6,077→ 86,942 total
  • Tax Payment

    Common Stock

    2017-03-10$6.68/sh−1,859$12,418→ 85,083 total
  • Exercise/Conversion

    Restricted Stock Unit

    2017-03-09−25,000→ 50,000 total
    → Common Stock (25,000 underlying)
  • Award

    Common Stock Option

    2017-03-10$6.68/sh+100,000$668,000→ 100,000 total
    Exercise: $6.68From: 2017-03-10Exp: 2027-03-10→ Common Stock (100,000 underlying)
  • Award

    Restricted Stock Unit

    2017-03-10+61,300→ 61,300 total
    → Common Stock (61,300 underlying)
  • Exercise/Conversion

    Common Stock

    2017-03-09+25,000→ 88,513 total
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units is as follows: 25,000 shares vested on March 9, 2017; 25,000 shares will vest on March 9, 2018; 25,000 shares will vest on March 9, 2019. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.
  • [F2]These restricted stock units vested 100% on the March 10, 2017 grant date.
  • [F3]The vesting schedule for the 100,000 options is as follows: 25,000 shares vested on March 10, 2017; 25,000 shares will vest on March 10, 2018; 25,000 shares will vest on March 10, 2019; 25,000 shares will vest on March 10, 2020
  • [F4]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,433 shares will vest on March 10, 2018; 20,434 shares will vest on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested units of restricted stock can be settled in shares of common stock, cash or a combination of both.

Documents

1 file

Issuer

INOVIO PHARMACEUTICALS, INC.

CIK 0001055726

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001055726

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:43 PM ET
Size
16.1 KB
View on SEC.gov